title: [Priapism secondary to chronic myeloid leukemia: value of initial treatment with cavernous lavage plus adjuvant methoxamine].
abstract: OBJECTIVE
  To report a case of priapism secondary to leukemia, with special reference to the initial treatment in the emergency services.
  
  
  METHODS
  A 53-year-old male with chronic myeloid leukemia presented with prolonged involuntary painful erection of 12 hours' duration. The physical examination and particularly the cavernosal blood gas study, indicated low flow priapism. Punction-lavage of the corpora cavernosa was performed. Because complete response was not achieved with this procedure, adjuvant intracavernous methoxamine was administered.
  
  
  RESULTS
  Complete detumescence was achieved after the third dose of methoxamine. There was no recurrence and erectile function was preserved.
  
  
  CONCLUSIONS
  We underscore the utility of combined cavernous lavage + adjuvant alpha-1 adrenergic agonist as initial therapy in priapism with this special etiology.
authors.affiliation: Servicio de Urología, Hospital Ramón y Cajal, Madrid.
authors.forename: Nicolás Alberto
authors.initials: NA
authors.lastname: Cruz Guerra
authors.forename: Luis Clemente
authors.initials: LC
authors.lastname: Ramos
authors.forename: Ana
authors.initials: A
authors.lastname: Linares Quevedo
authors.forename: Javier
authors.initials: J
authors.lastname: Sáenz Medina
authors.forename: Bernabé
authors.initials: B
authors.lastname: Pozo Mengual
authors.forename: Antonio
authors.initials: A
authors.lastname: Allona Almagro
mesh_terms: D000316:Adrenergic alpha-Agonists / Q000627:therapeutic use*; D017024:Chemotherapy, Adjuvant; D002908:Chronic Disease; D006801:Humans; D007951:Leukemia, Myeloid / Q000150:complications*; D008297:Male; D008729:Methoxamine / Q000627:therapeutic use*; D008875:Middle Aged; D011317:Priapism / Q000209:etiology* / Q000628:therapy*; D007507:Therapeutic Irrigation
chemical_list: D000316:Adrenergic alpha-Agonists; D008729:Methoxamine
vernacular_title: Priapismo secundario a leucemia mieloide crónica: valor del tratamiento inicial con lavado cavernoso más metoxamina adyuvante.